murthy.com HomeVisit USAStudent VisaWork VisaGreen CardCitizenshipfamilyMisc
Search
 

Attorney
Law Firm
Practice
Affiliation
Rating
Mission
Community
Worldwide
Contact
















Murthy Success Story : Rapid NIW Approval
Posted Jan 06, 2006
©MurthyDotCom
In
November and December of 2005, MurthyDotCom and MurthyBulletin readers were provided with examples of National Interest Waiver (NIW) and Extraordinary Ability (EA) cases filed by the Murthy Law Firm that received approvals. Our firm also received an NIW approval remarkable for its speed. The case was filed just prior to September 30, 2005, as part of our push to file eligible cases for nationals of India before EB2 retrogression was to go into effect. Happily, it was approved just one month later, at the end of October 2005. This is quite unusual and we are very pleased, as is our client. The substance of the case follows. It is an example of the types of proof and the arguments that have helped the Murthy Law Firm obtain approvals in NIW cases for many of our clients.
©MurthyDotCom
Field of NIW Work
©MurthyDotCom
Our client conducted leading work in the field of Free Radical Chemistry. The research focused on biosynthetic studies of potential anticancer compounds. Cancer research generally can be shown to be in the national interest, as the development of new cancer treatments is a high research priority in the United States. Our client conducted important research on free radicals, which are potentially harmful atoms or molecules within the body. Free radicals react with body chemicals and can cause disease, including cancer and immune-deficiency diseases. We argued that this individual’s research is of substantial benefit to the health of U.S. citizens and to the U.S. economy, as evidenced by research funding through the National Institutes of Health (NIH) and the National Science Foundation (NSF).
©MurthyDotCom
Documentary Evidence Submitted with NIW Filing
©MurthyDotCom
Our firm submitted reference letters on our client's behalf from U.S. and international universities and private institutions. These expert opinion letters stated, in sum, that our client is considered an international leader in the field, who has made substantial contributions to the field of cancer research. Nine publications were authored by this individual, including articles in leading journals and invited book chapters. Our client presented research at prestigious conferences, including the highly-select Gordon Research Conferences. We were able to show that other researchers are building upon our client's important and essential research findings, as demonstrated by more than seventy favorable citations to the work that has been done. This scientist is also a member of several professional organizations related to the field, including Phi Lambda Upsilon and the American Chemical Society.
©MurthyDotCom
Conclusion
©MurthyDotCom
We at the Murthy Law Firm would like to thank our client for agreeing to share this information with MurthyDotCom and MurthyBulletin readers. Our diligence in preparing this case prior to the EB2 retrogression was rewarded with a remarkably prompt NIW approval. Visit our NIW section on MurthyDotCom to read accounts of many other successes.



Copyright © 2006, MURTHY LAW FIRM. All Rights Reserved





 
 

Posted Jan 06, 2006